Navigation Links
China Biologic Reports Financial Results for the Third Quarter and First Nine Months of 2013
Date:11/5/2013

>Financial statements follow.

 CHINA BIOLOGIC PRODUCTS, INC. AND SUBSIDIARIES UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOMEFor the three months ended For the nine months ended September 30, September 30,September 30,September 30,2013201220132012USDUSDUSDUSDSales53,152,14153,124,050160,764,396150,817,850Cost of sales17,165,89716,921,28449,904,91748,767,900Gross profit 35,986,24436,202,766110,859,479102,049,950Operating expenses Selling expenses2,551,2453,545,3786,829,36512,536,727General and administrative expenses 9,218,79811,599,77926,771,96626,677,945Research and development expenses 1,053,383637,3972,801,6252,277,474Income from operations 23,162,81820,420,21274,456,52360,557,804Other income/ (expenses)Equity in income of an equity method investee 642,579744,9761,382,5242,219,279Change in fair value of derivative liabilities ---1,769,140Interest expense (306,656)(223,992)(741,569)(990,190)Interest income1,320,263561,7612,964,0821,870,873Other income, net -449,815-347,029Total other income, net 1,656,1861,532,5603,605,0375,216,131Earnings before income tax expense 24,819,00421,952,77278,061,56065,773,935Income tax expense 4,871,0413,479,68313,223,5929,990,014Net income 19,947,96318,473,08964,837,96855,783,921Less: Net income attributable to noncontrolling interest 5,251,9404,855,93919,064,15916,370,694Net income attributable to China Biologic Products, Inc. 14,696,02313,617,15045,773,80939,413,227Net income per share of common stock: Basic 0.550.511.711.51Diluted 0.530.501.641.41Weighted average shares used in computation: Basic 26,288,15426,546,92926,649,56326,009,707Diluted 27,449,08127,018,90427,780,00526,741,713Net income 19,947,96318,473,08964,837,96855,783,921Other comprehensive income :Foreign currency t
'/>"/>

SOURCE China Biologic Products, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15

Related medicine technology :

1. Governor-General of Australia Ms. Bryce Visits Sichuan University and Investigates Australia Cochlear Cochlea Project in West China Hospital, Sichuan University
2. The Medical Device Market: China
3. China Biologic Products to Report Third Quarter 2013 Financial Results
4. MEDTEC China 2013: Close to 8,000 Industry Professionals Make Show an Outstanding Success
5. What U.S. Doctors Know That Has Not Yet Reached China
6. PharmaPoint: Alzheimers Disease - China Drug Forecast and Market Analysis to 2022
7. Micell Technologies Announces Development and Distribution Agreement to Bring MiStent SES to China
8. China Nepstar Chain Drugstore Schedules Annual General Meeting of Shareholders for October 25, 2013
9. MEDTEC China 2013: Shaping Up to be The Most Successful Event Ever
10. PharmaPoint: Dry Eye Syndrome - China Drug Forecast and Market Analysis to 2022
11. Ventana receives approval from Chinas FDA for first fully automated IHC companion diagnostic identifying ALK protein expression in lung cancer patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/28/2015)... 28, 2015 Mike Rowe , spokesperson and ... Good Neighbor Pharmacy,s 2015 ThoughtSpot conference and ... Las Vegas, Nev. ... Do It," and Discovery Channel,s, "Dirty Jobs," Mr. Rowe spent ... "unsung heroes" – people whose hard work, sacrifice and value ...
(Date:7/28/2015)... Inc. (NYSE: CRY ), a leading medical device ... surgery, announced today its results for the second quarter ... Pat Mackin, Chairman, President and Chief Executive Officer, said, ... growth strategy with solid progress on several of our ... transition to a direct sales model in France, advancing ...
(Date:7/28/2015)... 28, 2015 Dipexium Pharmaceuticals, Inc. (NASDAQ: ... on the development and commercialization of Locilex® (pexiganan ... data will be presented at the American Society ... Chemotherapy and International Society of Chemotherapy,s International Congress ... in San Diego, California , ...
Breaking Medicine Technology:Mike Rowe to Address Community Pharmacists at ThoughtSpot 2015 2CryoLife Reports Second Quarter Financial Results 2CryoLife Reports Second Quarter Financial Results 3CryoLife Reports Second Quarter Financial Results 4CryoLife Reports Second Quarter Financial Results 5CryoLife Reports Second Quarter Financial Results 6CryoLife Reports Second Quarter Financial Results 7CryoLife Reports Second Quarter Financial Results 8CryoLife Reports Second Quarter Financial Results 9CryoLife Reports Second Quarter Financial Results 10CryoLife Reports Second Quarter Financial Results 11CryoLife Reports Second Quarter Financial Results 12CryoLife Reports Second Quarter Financial Results 13CryoLife Reports Second Quarter Financial Results 14Dipexium Pharmaceuticals' Pexiganan Demonstrates Microbiological Activity Against Pathogens Resistant to other Topical Antibiotics 2Dipexium Pharmaceuticals' Pexiganan Demonstrates Microbiological Activity Against Pathogens Resistant to other Topical Antibiotics 3
... Sunesis,Pharmaceuticals, Inc. (Nasdaq: SNSS ) today announced ... in Elderly AML) Phase 2 clinical,trial of voreloxin ... The REVEAL-1 trial is being conducted in previously ... are unlikely to,benefit from standard induction therapy. The ...
... EASTON, Mass., May 21 Pressure,BioSciences, Inc. (Nasdaq: ... the New York University (NYU) School of Medicine, ... Public Health made presentations,highlighting the advantages of the ... scientific meetings earlier this week.,There were three oral ...
Cached Medicine Technology:Sunesis Pharmaceuticals Initiates Phase 2 Clinical Trial of Voreloxin (SNS-595) in Acute Myeloid Leukemia 2Sunesis Pharmaceuticals Initiates Phase 2 Clinical Trial of Voreloxin (SNS-595) in Acute Myeloid Leukemia 3Sunesis Pharmaceuticals Initiates Phase 2 Clinical Trial of Voreloxin (SNS-595) in Acute Myeloid Leukemia 4Sunesis Pharmaceuticals Initiates Phase 2 Clinical Trial of Voreloxin (SNS-595) in Acute Myeloid Leukemia 5Seven Presentations by Two Independent Research Groups Highlight Advantages of Pressure Cycling Technology (PCT) at Scientific Symposia in Philadelphia, Boston, and New York City 2Seven Presentations by Two Independent Research Groups Highlight Advantages of Pressure Cycling Technology (PCT) at Scientific Symposia in Philadelphia, Boston, and New York City 3Seven Presentations by Two Independent Research Groups Highlight Advantages of Pressure Cycling Technology (PCT) at Scientific Symposia in Philadelphia, Boston, and New York City 4
(Date:7/28/2015)... Ethiopia (PRWEB) , ... July 28, 2015 , ... ... during U.S. President Barack Obama’s visit to Ethiopia to learn more about the ... the Future Initiative . This initiative focuses on accelerating agricultural development as an ...
(Date:7/28/2015)... ... July 28, 2015 , ... opaJUMP! and O-PA! Performance ... health outcomes associated with its training methods. This company is also the first ... study, conducted in early 2015, training yielded an average 80% improvement in functional ...
(Date:7/28/2015)... ... July 28, 2015 , ... Healthpointe ’s Cosmetic ... returns skin to a smooth state, and reduces the appearance of fine lines and ... only FDA-approved injectable gel to instantly add volume to your cheek area to correct ...
(Date:7/28/2015)... ... July 28, 2015 , ... Bipolar disorder is often associated with ... a few times a year. The World Health Organization (WHO) has reported that bipolar ... of Mental Health reveals that the United States has the highest lifetime rate of ...
(Date:7/28/2015)... ... July 28, 2015 , ... A new Taiwanese ... than they are in the general population. Surviving Mesothelioma has just posted an ... , Researchers at Taiwan’s National Health Research Institutes and three Taiwanese universities evaluated ...
Breaking Medicine News(10 mins):Health News:US President learns from DuPont Innovations in Food and Agriculture in Ethiopia 2Health News:US President learns from DuPont Innovations in Food and Agriculture in Ethiopia 3Health News:US President learns from DuPont Innovations in Food and Agriculture in Ethiopia 4Health News:opaJUMP Launches First Case Study in Thyroid Health: How Rebounding Helped One Woman Stabilize Her Thyroid in Seven Weeks 2Health News:opaJUMP Launches First Case Study in Thyroid Health: How Rebounding Helped One Woman Stabilize Her Thyroid in Seven Weeks 3Health News:opaJUMP Launches First Case Study in Thyroid Health: How Rebounding Helped One Woman Stabilize Her Thyroid in Seven Weeks 4Health News:opaJUMP Launches First Case Study in Thyroid Health: How Rebounding Helped One Woman Stabilize Her Thyroid in Seven Weeks 5Health News:opaJUMP Launches First Case Study in Thyroid Health: How Rebounding Helped One Woman Stabilize Her Thyroid in Seven Weeks 6Health News:opaJUMP Launches First Case Study in Thyroid Health: How Rebounding Helped One Woman Stabilize Her Thyroid in Seven Weeks 7Health News:Healthpointe’s Cosmetic Laser Institute Now Providing Juvéderm Voluma XC in Anaheim 2Health News:Healthpointe’s Cosmetic Laser Institute Now Providing Juvéderm Voluma XC in Anaheim 3Health News:"I Am Not I" Music Video Raises Bipolar Disorder Awareness 2Health News:New Findings Suggest Mesothelioma is Not the Only Cancer Threat for Shipbreakers, According to Surviving Mesothelioma 2
... HealthDay Reporter , FRIDAY, June 24 (HealthDay News) -- Autism ... engineers and computer programmers who have autistic children compared to, ... to those observations. Researchers from Cambridge University in England ... with an autism spectrum disorder in a region of the ...
... News) -- Snacking accounts for 25 percent of the calories ... of those snacking calories, a new study indicates. Since ... that averages 580 calories per day, said Richard D. Mattes, ... West Lafayette, Ind. Because many Americans don,t think about ...
... thousands of tiny worms and a homegrown invention to ... Disease. A team of researchers from the faculties ... $450,000 grant from the Collaborative Health Research Projects program, ... to search for effective new drugs to treat the ...
... , FRIDAY, June 24 (HealthDay News) -- Among U.S. drivers ... positive for drugs, a new study has found. Most commonly, ... such as cocaine and amphetamines, and each of these drugs accounted ... in the July issue of the Journal of Studies on ...
... study confirms that medications with anticholinergic activity, which include ... impairment. The research is also the first to identify ... over-the-counter and prescription sleep aids and incontinence treatments ... the impact of these medications on 13,000 men and ...
... HealthDay Reporter , THURSDAY, June 23 (HealthDay News) -- ... salad dressing appeal to many, but new evidence indicates that ... foods and that those who can,t may end up eating ... presented at the 2011 Institute of Food Technologists annual meeting ...
Cached Medicine News:Health News:More Autism Diagnoses in High-Tech Areas, Study Finds 2Health News:More Autism Diagnoses in High-Tech Areas, Study Finds 3Health News:Tiny worms head into the breach as team searches for Parkinson's treatment 2Health News:Drug Use May Play Role in 25% of Driver Deaths, Study Finds 2Health News:Common drugs linked to cognitive impairment and possibly to increased risk of death 2Health News:Common drugs linked to cognitive impairment and possibly to increased risk of death 3Health News:Poor 'Fat-Tasters' May Tend to Be Heavier 2Health News:Poor 'Fat-Tasters' May Tend to Be Heavier 3
... The Gemini Family of infusion ... with a collective series of ... product line offers a wide ... IV sets, each featuring the ...
... any hospital or health system can take ... effective tools available for physicians and nurses. ... and electronic medical record (EMR) system, helps ... In fact, its the most reliable clinical ...
... These specialty Eraser instruments have ... surgeon with the right tool for ... introduced a series of 25 gauge ... provide discrete treatment of target tissues ...
... Care, the world-class clinician documentation and electronic ... focus on the specific needs of intensive ... Its broad, deep clinical functionality has secured ... EMR solution in critical care, and its ...
Medicine Products: